{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug resistance", "engineered abcb4 expression model"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35165900", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1002/ddr.21917"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "83", "Issue": "4", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "An engineered abcb4 expression model reveals the central role of NF-\u03baB in the regulation of drug resistance in zebrafish.", "Pagination": {"StartPage": "927", "EndPage": "939", "MedlinePgn": "927-939"}, "Abstract": {"AbstractText": ["Multi-drug resistance (MDR) is a phenomenon that tumor cells are exposed to a chemotherapeutic drug for a long time and then develop resistance to a variety of other anticancer drugs with different structures and different mechanisms. The in vitro studies of tumor cell lines cannot systematically reflect the role of MDR gene in vivo, and the cost of in vivo studies of transgenic mice as animal models is high. Given the myriad merits of zebrafish relative to other animal models, we aimed to establish a screening system using zebrafish stably expressing ATP-binding cassette (ATP-cassette) superfamily transporters and unveil the potential regulatory mechanism. We first used the Tol2-mediated approach to construct a Tg (abcb4:EGFP) transgenic zebrafish line with ATP-binding cassette (ABC) subfamily B member 4 (abcb4) gene promoter to drive EGFP expression. The expression levels of abcb4 and EGFP were significantly increased when Tg(abcb4:EGFP) transgenic zebrafish embryos were exposed to doxorubicin (DOX) or vincristine (VCR), and the increases were accompanied by a marked decreased accumulation of rhodamine B (RhB) in embryos, indicating a remarkable increase in DOX or VCR efflux. Mechanistically, Akt and Erk signalings were activated upon the treatment with DOX or VCR. With the application of Akt and Erk inhibitors, drug resistance was reversed with differing responsive effects. Notably, downstream NF-\u03baB played a central role in the regulation of abcb4-mediated drug resistance. Taken together, the data indicate that the engineered Tg(abcb4:EGFP) transgenic zebrafish model is a new platform for screening drug resistance in vivo, which may facilitate and accelerate the process of drug development."], "CopyrightInformation": "\u00a9 2022 Wiley Periodicals, LLC."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Province Key Laboratory for Regenerative Medicine, Department of Immunology, Department of Pediatrics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences, Guiyang, China."}], "LastName": "Sun", "ForeName": "Cong-Jie", "Initials": "CJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Province Key Laboratory for Regenerative Medicine, Department of Immunology, Department of Pediatrics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences, Guiyang, China."}], "LastName": "Hu", "ForeName": "Rong-Yin", "Initials": "RY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Province Key Laboratory for Regenerative Medicine, Department of Immunology, Department of Pediatrics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences, Guiyang, China."}], "LastName": "Li", "ForeName": "Zhi-Cao", "Initials": "ZC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Province Key Laboratory for Regenerative Medicine, Department of Immunology, Department of Pediatrics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences, Guiyang, China."}], "LastName": "Jin", "ForeName": "Lu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Health and Medical Research, Medical Research Unit 942/Paris University 7 and 13, Avicenne Hospital, Bobigny, France."}], "LastName": "Lu", "ForeName": "He", "Initials": "H"}, {"Identifier": ["0000-0002-2229-827X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Province Key Laboratory for Regenerative Medicine, Department of Immunology, Department of Pediatrics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Department of Pediatrics, Zunyi Medical University, Zunyi, China."}], "LastName": "He", "ForeName": "Zhi-Xu", "Initials": "ZX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Adult Stem Cell Translational Research, Chinese Academy of Medical Sciences, Guiyang, China."}, {"Identifier": [], "Affiliation": "National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, State Key Laboratory of Functions and Applications of Medicinal Plants, Guiyang, China."}], "LastName": "Shu", "ForeName": "Li-Ping", "Initials": "LP"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ATP-Binding Cassette Transporters"}, {"RegistryNumber": "0", "NameOfSubstance": "Abcb4 protein, zebrafish"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Zebrafish Proteins"}, {"RegistryNumber": "5J49Q6B70F", "NameOfSubstance": "Vincristine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": ["genetics", "metabolism"], "DescriptorName": "ATP-Binding Cassette Transporters"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Animals, Genetically Modified"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Resistance"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vincristine"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Zebrafish"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Zebrafish Proteins"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Andersen, V., Vogel, U., Godiksen, S., Frenzel, F. B., Saebo, M., Hamfjord, J., & Vogel, L. K. (2013). Low ABCB1 gene expression is an early event in colorectal carcinogenesis. PLoS One, 8(8), e72119."}, {"Citation": "Asakawa, K., Suster, M. L., Mizusawa, K., Nagayoshi, S., Kotani, T., Urasaki, A., & Kawakami, K. (2008). Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish. Proceedings of the National Academy of Sciences of the United States of America, 105(4), 1255-1260."}, {"Citation": "Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., & Bours, V. (2003). NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22(1), 90-97."}, {"Citation": "Beretta, G. L., Cassinelli, G., Pennati, M., Zuco, V., & Gatti, L. (2017). Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents. European Journal of Medicinal Chemistry, 142, 271-289."}, {"Citation": "Bieczynski, F., Burkhardt-Medicke, K., Luquet, C. M., Scholz, S., & Luckenbach, T. (2021). Chemical effects on dye efflux activity in live zebrafish embryos and on zebrafish Abcb4 ATPase activity. FEBS Letters, 595(6), 828-843."}, {"Citation": "Binkhathlan, Z., & Lavasanifar, A. (2013). P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: Current status and future perspectives. Current Cancer Drug Targets, 13(3), 326-346."}, {"Citation": "Ch, C. (2005). ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell International, 5, 30."}, {"Citation": "Delou, J. M. A., Vignal, G. M., Indio-do-Brasil, V., Accioly, M. T. S., da Silva, T. S. L., Piranda, D. N., & Vianna-Jorge, R. (2017). Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis. Breast Cancer, 9, 415-428."}, {"Citation": "Du, B., & Shim, J. S. (2016). Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules, 21(7), 965."}, {"Citation": "Eadie, L. N., Dang, P., Saunders, V. A., Yeung, D. T., Osborn, M. P., Grigg, A. P., & White, D. L. (2017). The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment. Leukemia, 31(1), 75-82."}, {"Citation": "Fischer, S., Kl\u00fcver, N., Burkhardt-Medicke, K., Pietsch, M., Schmidt, A. M., Wellner, P., & Luckenbach, T. (2013). Abcb4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos. BMC Biology, 11, 69."}, {"Citation": "Fleming, A., Diekmann, H., & Goldsmith, P. (2013). Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish. PLoS One, 8(10), e77548."}, {"Citation": "Fletcher, J. I., Williams, R. T., Henderson, M. J., Norris, M. D., & Haber, M. (2016). ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resistance Updates, 26, 1-9."}, {"Citation": "Gottesman, M. M., Fojo, T., & Bates, S. E. (2002). Multidrug resistance in cancer: Role of ATP-dependent transporters. Nature Reviews. Cancer, 2(1), 48-58."}, {"Citation": "Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017). Little fish, big data: Zebrafish as a model for cardiovascular and metabolic disease. Physiological Reviews, 97(3), 889-938."}, {"Citation": "Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nature Reviews. Cancer, 13(10), 714-726."}, {"Citation": "Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014). Drug resistance in cancer: An overview. Cancers (Basel), 6(3), 1769-1792."}, {"Citation": "Jackson, J. S., & Kennedy, C. J. (2017). Regulation of hepatic abcb4 and cyp3a65 gene expression and multidrug/multixenobiotic resistance (MDR/MXR) functional activity in the model teleost, Danio rerio (zebrafish). Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 200, 34-41."}, {"Citation": "Kamada, K., Kabat, P., & Hino, S. (2004). Transcriptional regulation of TT virus: Promoter and enhancer regions in the 1.2-kb noncoding region. Virology, 321(3), 341-348."}, {"Citation": "Kawakami, K., Takeda, H., Kawakami, N., Kobayashi, M., Matsuda, N., & Mishina, M. (2004). A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Developmental Cell, 7(1), 133-144."}, {"Citation": "Kiehl, S., Richter, A. M., Fuhrmann, L., El-Nikhely, N., Seeger, W., Savai, R., & Dammann, R. H. (2014). ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth. Scientific Reports, 4, 6899."}, {"Citation": "Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., & Kohno, S. (2005). Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. Lung Cancer, 49(3), 337-343."}, {"Citation": "Koeffler, H. P. (1980). Human myeloid leukemia cell lines: A review. Blood, 56(3), 344-350."}, {"Citation": "Lessman, C. A. (2011). The developing zebrafish (Danio rerio): A vertebrate model for high-throughput screening of chemical libraries. Birth Defects Research. Part C, Embryo Today, 93(3), 268-280."}, {"Citation": "Li, S., Zhang, W., Yin, X., Xing, S., Xie, H. Q., Cao, Z., & Zhao, B. (2015). Mouse ATP-binding cassette (ABC) transporters conferring multi-drug resistance. Anti-Cancer Agents in Medicinal Chemistry, 15(4), 423-432."}, {"Citation": "Linnerz, T., & Hall, C. J. (2020). The diverse roles of phagocytes during bacterial and fungal infections and sterile inflammation: Lessons from zebrafish. Frontiers in Immunology, 11, 1094."}, {"Citation": "Liu, B., Li, L. J., Gong, X., Zhang, W., Zhang, H., & Zhao, L. (2018). Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia. Oncology Letters, 15(5), 6671-6677."}, {"Citation": "Liu, H., Su, J., Ma, J., Qin, Y., Ji, L., Geng, H., Wang, S., Zhang, P., Liu, J., Cui, S., Ge, R. L., & Li, Z. (2020). EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness. Blood Cells, Molecules & Diseases, 84, 102446."}, {"Citation": "Long, Y., Zhong, S., Wang, Y., & Cui, Z. (2011). Molecular characterization and functions of zebrafish ABCC2 in cellular efflux of heavy metals. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 153(4), 381-391."}, {"Citation": "Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., & Haber, D. A. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England Journal of Medicine, 350(21), 2129-2139."}, {"Citation": "McCurley, A. T. (2008). Characterization of housekeeping genes in zebrafish: Male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Molecular Biology, 9, 102."}, {"Citation": "Mealey, K. L. (2013). Adverse drug reactions in veterinary patients associated with drug transporters. The Veterinary Clinics of North America. Small Animal Practice, 43(5), 1067-1078."}, {"Citation": "Nikolaou, M., Pavlopoulou, A., Georgakilas, A. G., & Kyrodimos, E. (2018). The challenge of drug resistance in cancer treatment: A current overview. Clinical & Experimental Metastasis, 35(4), 309-318."}, {"Citation": "Requenez-Contreras, J. L., Lopez-Castillejos, E. S., Hernandez-Flores, R., Moreno-Eutimio, M. A., Granados-Riveron, J. T., Martinez-Ruiz, G. U., & Aquino-Jarquin, G. (2017). MiR-138 indirectly regulates the MDR1 promoter by NF-kappaB/p65 silencing. Biochemical and Biophysical Research Communications, 484(3), 648-655."}, {"Citation": "Robey, R. W., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nature Reviews. Cancer, 18(7), 452-464."}, {"Citation": "Shostak, K., & Chariot, A. (2015). EGFR and NF-kappaB: Partners in cancer. Trends in Molecular Medicine, 21(6), 385-393."}, {"Citation": "Shu, L. P., Zhou, Z. W., Zhou, T., Deng, M., Dong, M., Chen, Y., & He, Z. X. (2015). Ectopic expression of Hoxb4a in hemangioblasts promotes hematopoietic development in early embryogenesis of zebrafish. Clinical and Experimental Pharmacology & Physiology, 42(12), 1275-1286."}, {"Citation": "Sun, C. J., He, Z. X., Shu, L. P., Hu, R. Y., & He, S. J. (2016). Effect of doxorubicin on abcb4 gene expression in zebrafish (Danio rerio) embryos. Sichuan Da Xue Xue Bao Yi Xue Ban, 47(1), 7-13."}, {"Citation": "Sun, S., Cai, J., Yang, Q., Zhu, Y., Zhao, S., & Wang, Z. (2016). Prognostic value and implication for chemotherapy treatment of ABCB1 in epithelial ovarian cancer: A meta-analysis. PLoS One, 11(11), e0166058."}, {"Citation": "Sun, Y., Wang, C., Meng, Q., Liu, Z., Huo, X., Sun, P., & Liu, K. (2018). Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and ca(2+)-mediated apoptosis pathways in MCF-7/ADR and K562/ADR. Journal of Cellular Physiology, 233(4), 3066-3079."}, {"Citation": "Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery, 5(3), 219-234."}, {"Citation": "Tamplin, O. J., White, R. M., Jing, L., Kaufman, C. K., Lacadie, S. A., Li, P., & Zon, L. I. (2012). Small molecule screening in zebrafish: Swimming in potential drug therapies. Wiley Interdisciplinary Reviews: Developmental Biology, 1(3), 459-468."}, {"Citation": "Tsubaki, M., Takeda, T., Ogawa, N., Sakamoto, K., Shimaoka, H., Fujita, A., & Nishida, S. (2015). Overexpression of survivin via activation of ERK1/2, Akt, and NF-kappaB plays a central role in vincristine resistance in multiple myeloma cells. Leukemia Research, 39(4), 445-452."}, {"Citation": "Wang, H., Jia, X. H., Chen, J. R., Wang, J. Y., & Li, Y. J. (2016). Osthole shows the potential to overcome P-glycoproteinmediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway. Oncology Reports, 35(6), 3659-3668."}, {"Citation": "Westerfield, M. (1993). The zebrafish book: A guide for the laboratory use of zebrafish (Brachydanio rerio). Monte Westerfield."}, {"Citation": "Wiley, D. S., Redfield, S. E., & Zon, L. I. (2017). Chemical screening in zebrafish for novel biological and therapeutic discovery. Methods in Cell Biology, 138, 651-679."}, {"Citation": "Xie, X., Tang, B., Zhou, J., Gao, Q., & Zhang, P. (2013). Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Oncology Reports, 30(2), 773-782."}, {"Citation": "Yang, X., Ding, Y., Xiao, M., Liu, X., Ruan, J., & Xue, P. (2017). Anti-tumor compound RY10-4 suppresses multidrug resistance in MCF-7/ADR cells by inhibiting PI3K/Akt/NF-kappaB signaling. Chemico-Biological Interactions, 278, 22-31."}, {"Citation": "Zhao, B. X., Sun, Y. B., Wang, S. Q., Duan, L., Huo, Q. L., Ren, F., & Li, G. F. (2013). Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-kappaB and MAPK/ERK mediated YB-1 activity in A2780/T cells. PLoS One, 8(8), e71071."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2022", "Month": "1", "Day": "4"}, {"Year": "2021", "Month": "6", "Day": "28"}, {"Year": "2022", "Month": "1", "Day": "10"}, {"Year": "2022", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "5", "Minute": "38"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35165900", "10.1002/ddr.21917"]}}], "PubmedBookArticle": []}